Abstract
Endothelial cells play a central role in inflammatory responses, mediating leukocyte and solute traffic from blood vessels into the tissue, and are therefore key targets for anti-inflammatory therapies. Phosphoinositide 3-kinases (PI3Ks) are important signal transducers in inflammation and cancer, however there are 8 different PI3K catalytic isoforms, several of which have been shown to play distinct roles in cellular responses. Isoform-selective inhibitors have recently been described, but their effects on endothelial cell responses have not been compared. Here we compare the effects of the pan-PI3K inhibitor wortmannin with that of four more isoform-selective inhibitors, PI-103, TGX-221, AS604850 and IC87114, on endothelial cells stimulated with the pro-inflammatory cytokine TNFα. We find that PI-103 and wortmannin are most effective at reducing both endothelial permeability and leukocyte transendothelial migration (TEM), which correlates with a decrease in both the activity of the tyrosine kinase Pyk2 and its association with VE-cadherin. PI-103-related compounds are therefore likely to be good candidates for treating chronic inflammatory responses involving TNFα.
Original language | English |
---|---|
Pages (from-to) | 1929-1936 |
Number of pages | 8 |
Journal | International Journal of Biochemistry and Cell Biology |
Volume | 44 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2012 |
Keywords
- Adenine
- Androstadienes
- Antigens, CD
- Cadherins
- Capillary Permeability
- Cell Membrane Permeability
- Cell Shape
- Class Ia Phosphatidylinositol 3-Kinase
- Dioxoles
- Endothelial Cells
- Focal Adhesion Kinase 2
- Furans
- Human Umbilical Vein Endothelial Cells
- Humans
- Leukocytes
- Phosphatidylinositol 3-Kinases
- Phosphorylation
- Protein Binding
- Protein Kinase Inhibitors
- Proto-Oncogene Proteins c-akt
- Pyridines
- Pyrimidines
- Quinazolines
- Signal Transduction
- TOR Serine-Threonine Kinases
- Thiazolidinediones
- Transendothelial and Transepithelial Migration
- Tumor Necrosis Factor-alpha